Published research has indicated that this molecule acts as a potent HDAC inhibitor at sub-IC50 and at IC50s in the nanomolar range (IC50 = 60 nM) for non-small cell lung cancer cells (NSCLC H1299 cells). The gene discussed is HDAC9; the disease is non-small cell lung carcinoma.